News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
Thursday, February 12, 2026Novocure has received approval from the US Food and Drug Administration FDA for Optune Pax for the treatment of adults with locally advanced pancreatic cancer The device is approved for use together
ArisGlobal Launches XDI NavaX Data Intelligence with Three New Agents and NavaX Translation in Madrid
Wednesday, February 11, 2026ArisGlobal a leader in AIdriven Life Sciences technology announced the launch of XDI NavaX Data Intelligence featuring three new agents and NavaX Translation on February in Madrid
THX Pharma and Biocodex Sign Strategic Licensing Agreement for Rare Disease Drug Candidates
Wednesday, February 11, 2026THX Pharma and Biocodex an independent international pharmaceutical group have entered into a strategic licensing agreement to advance two drug candidates targeting three rare diseases with high unmet medical need
Kincell Bio Partners with RegCell to Support Clinical Development of Treg Cell Therapies for Autoimmune Diseases
Wednesday, February 11, 2026Kincell Bio a USbased cell therapy contract development and manufacturing organisation CDMO has announced a collaboration with RegCell a biotechnology company developing an immune tolerance platform
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Tuesday, February 10, 2026The EU Parliament has progressed the Critical Medicines Act aimed at enhancing Europes pharmaceutical supply chain resilience starting in
Evinova and Bristol Myers Squibb Partner to Use AI in Clinical Development
Tuesday, February 10, 2026Evinova has entered into a strategic agreement with Bristol Myers Squibb to support the optimisation of clinical trials using artificial intelligence As part of the collaboration Bristol Myers Squibb will use the Cost Optimizer module within Evinovas...
Krystal Biotech Secures FDA RMAT Designation for KB707 in Advanced Lung Cancer
Tuesday, February 10, 2026Krystal Biotech has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration for KB its redosable immunotherapy for the treatment of advanced or metastatic nonsmall cell lung cancer NSCLC
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Monday, February 09, 2026The European Parliament adopted its position on the Critical Medicines Act on January advancing negotiations to enhance Europes pharmaceutical supply chain resilience and competitiveness
Recent EU Life Sciences Regulatory Changes – What You Need to Know
Friday, February 06, 2026The EU has reached political agreement on the Pharma Package and proposed simplifications to medical devices regulations alongside a new Biotech Act to boost competitiveness
Breckenridge Pharmaceutical Enters Strategic Collaboration with Medichem
Friday, February 06, 2026Breckenridge Pharmaceutical Inc the US subsidiary of Towa International has entered into a strategic collaboration with Medichem Solutions SL a subsidiary of Medichem The agreement covers a range of injectable medicines
